GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
NASDAQ:OASM
Delisted

Oasmia Pharmaceutical AB Stock Forecast

$1.42
+0.0050 (+0.353%)
At Close: Feb 07, 2020
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Oasmia Pharmaceutical AB stock upgraded from Sell Candidate to Hold/Accumulate after Friday trading session.
(Updated on Feb 07, 2020)

Hold candidate since Feb 07, 2020 PDF

The Oasmia Pharmaceutical AB stock price gained 0.353% on the last trading day (Friday, 7th Feb 2020), rising from $1.42 to $1.42. During the last trading day the stock fluctuated 0% from a day low at $1.42 to a day high of $1.42. The price has risen in 4 of the last 10 days but is still down by -8.39% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 195 more shares were traded than the day before. In total, 205 shares were bought and sold for approximately $291.10 .

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 7.62% during the next 3 months and, with a 90% probability hold a price between $1.32 and $1.96 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

OASM Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, February 03, 2020, and so far it has risen 6.97%. Further rise is indicated until a new top pivot has been found. Oasmia Pharmaceutical AB has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Oasmia Pharmaceutical AB stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.42 and $1.42. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Oasmia Pharmaceutical AB stock

Oasmia Pharmaceutical AB finds support from accumulated volume at $1.42 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 1.17%.

Our recommended stop-loss: $1.35 (-4.91%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 4 days ago.)

Trading Expectations (OASM) For The Upcoming Trading Day Of Monday 10th

For the upcoming trading day on Monday, 10th we expect Oasmia Pharmaceutical AB to open at $1.42, and during the day (based on 14 day Average True Range), to move between $1.29 and $1.55, which gives a possible trading interval of +/-$0.132 (+/-9.33%) up or down from last closing price. If Oasmia Pharmaceutical AB takes out the full calculated possible swing range there will be an estimated 18.66% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.42 (0.35%) than the resistance at $1.51 (5.99%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Oasmia Pharmaceutical AB stock A Buy?

Oasmia Pharmaceutical AB holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: 0.025 Hold/Accumulate Upgraded

Predicted Opening Price for Oasmia Pharmaceutical AB of Monday, February 10, 2020

Fair opening price February 10, 2020 Current price
$1.42 ( 0%) $1.42

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for OASM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.42 .
R2 1.42 .
R1 1.42 .
Current price: 1.42
Support S1 1.42 .
S2 1.42 .
S3 1.42 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.58 11.27 %
R2 1.52 6.69 %
R1 1.51 5.99 %
Current price 1.42
Support S1 1.42 -0.352%
S2 1.37 -3.52%
S3 1.34 -5.63%

FAQ

What is the symbol for Oasmia Pharmaceutical AB Stock and on which exchange is it traded?
The symbol for Oasmia Pharmaceutical AB is OASM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Oasmia Pharmaceutical AB Stock?
Oasmia Pharmaceutical AB holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Oasmia Pharmaceutical AB Stock?
Oasmia Pharmaceutical AB Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Oasmia Pharmaceutical AB Stock.

What's the current price of Oasmia Pharmaceutical AB Stock?
As of the end of day on the 2020-02-07, the price of an Oasmia Pharmaceutical AB (OASM) share was $1.42.

What is the 52-week high and low for Oasmia Pharmaceutical AB Stock?
The 52-week high for Oasmia Pharmaceutical AB Stock is $3.43 and the 52-week low is $0.94.
Click to get the best stock tips daily for free!

About Oasmia Pharmaceutical AB

Oasmia Pharmaceutical AB Oasmia Pharmaceutical AB (publ) develops, produces, markets, and sells drugs for human and veterinary oncology primarily in Sweden. It focuses on manufacturing formulations based on cytostatics. The companyÂ’s approved products include Paccal Vet-CA1 for the treatment of mammary carcinoma and squamous cell carcinoma in dogs; and Paclical for the treatment of ovarian cancer. It is also developing Paclical for the treatment of metastatic breast can... OASM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT